HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Folate receptor-targeted theranostic IrSx nanoparticles for multimodal imaging-guided combined chemo-photothermal therapy.

Abstract
Nano-drug delivery systems with multi-modality imaging capacities are worth pursuing because they integrate diagnostic and therapeutic functions. Herein, we report the design, synthesis and evaluation of modified iridium sulfide (IrSx) nanoparticles (NPs) for cancer therapy in vitro and in vivo. This nanosystem was prepared by modifying IrSx with polyethylene glycol (PEG) conjugated to the targeting ligand folate (FA) for multimodal imaging-guided combined chemo-photothermal therapy. Upon PEG modification, the small IrSx NPs (about 4 nm) self-assembled into much larger (about 120 nm) IrSx-PEG-FA NPs, which exhibited high photostability, ideal photothermal effect, high drug loading and pH-/photothermal-responsive drug release properties. By using the model anticancer drug camptothecin (CPT), we demonstrated that CPT@IrSx-PEG-FA can effectively target FA-receptor-positive cancer cells in vitro and show efficient tumor accumulation in vivo. The combination of CPT@IrSx-PEG-FA treatment and irradiation with an 808 nm laser resulted in complete tumor elimination. Moreover, photothermal/photoacoustic (PA)/computed tomography (CT) imaging provided an effective means to monitor the therapeutic effects. Interestingly, the nanoparticles can be cleared, resulting in low systematic toxicity of CPT@IrSx-PEG-FA. Our work demonstrates that the as-prepared IrSx-PEG-FA NPs present a promising platform for the construction of multifunctional theranostic agents for cancer therapy.
AuthorsDong-Yang Zhang , Yue Zheng , Hang Zhang , Gang-Gang Yang , Cai-Ping Tan , Liang He , Liang-Nian Ji , Zong-Wan Mao
JournalNanoscale (Nanoscale) Vol. 10 Issue 47 Pg. 22252-22262 (Dec 21 2018) ISSN: 2040-3372 [Electronic] England
PMID30465053 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Biocompatible Materials
  • Folate Receptor 1
  • Sulfides
  • Polyethylene Glycols
  • Iridium
  • Doxorubicin
  • Folic Acid
  • Camptothecin
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Biocompatible Materials (chemistry)
  • Camptothecin (administration & dosage)
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage)
  • Drug Delivery Systems
  • Drug Liberation
  • Folate Receptor 1 (chemistry)
  • Folic Acid
  • HeLa Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Hyperthermia, Induced
  • Iridium
  • MCF-7 Cells
  • Mice
  • Multimodal Imaging
  • Nanoparticles (chemistry, therapeutic use)
  • Photoacoustic Techniques
  • Phototherapy
  • Polyethylene Glycols (chemistry)
  • Sulfides
  • Theranostic Nanomedicine
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: